Protagonist Therapeutics, Inc.
ANALOGUES OF HEPCIDIN MIMETICS WITH IMPROVED IN VIVO HALF LIFES

Last updated:

Abstract:

The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.

Status:
Application
Type:

Utility

Filling date:

1 Oct 2020

Issue date:

20 May 2021